57 related articles for article (PubMed ID: 26480340)
1. 2-Guanidinoquinazolines as new inhibitors of the STAT3 pathway.
LaPorte MG; da Paz Lima DJ; Zhang F; Sen M; Grandis JR; Camarco D; Hua Y; Johnston PA; Lazo JS; Resnick LO; Wipf P; Huryn DM
Bioorg Med Chem Lett; 2014 Nov; 24(21):5081-5. PubMed ID: 25288188
[TBL] [Abstract][Full Text] [Related]
2. Allosteric regulation in STAT3 interdomains is mediated by a rigid core: SH2 domain regulation by CCD in D170A variant.
Zhao T; Karki N; Zoltowski BD; Matthews DA
PLoS Comput Biol; 2022 Dec; 18(12):e1010794. PubMed ID: 36542668
[TBL] [Abstract][Full Text] [Related]
3. Photoredox C-H functionalization leads the site-selective phenylalanine bioconjugation.
Weng Y; Su CJ; Jiang H; Chiang CW
Sci Rep; 2022 Nov; 12(1):18994. PubMed ID: 36348051
[TBL] [Abstract][Full Text] [Related]
4. Aberrant function of pathogenic STAT3 mutant proteins is linked to altered stability of monomers and homodimers.
Kasembeli MM; Kaparos E; Bharadwaj U; Allaw A; Khouri A; Acot B; Tweardy DJ
Blood; 2023 Mar; 141(12):1411-1424. PubMed ID: 36240433
[TBL] [Abstract][Full Text] [Related]
5. Identification and Validation of
Liu W; Zhu F; Yan J; Liu Y; Chen C; Zhang K; Zhao X; Chen J
Onco Targets Ther; 2020; 13():11165-11176. PubMed ID: 33173308
[TBL] [Abstract][Full Text] [Related]
6. Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.
Bharadwaj U; Kasembeli MM; Robinson P; Tweardy DJ
Pharmacol Rev; 2020 Apr; 72(2):486-526. PubMed ID: 32198236
[TBL] [Abstract][Full Text] [Related]
7. Stafia-1: a STAT5a-Selective Inhibitor Developed via Docking-Based Screening of in Silico O-Phosphorylated Fragments.
Natarajan K; Müller-Klieser D; Rubner S; Berg T
Chemistry; 2020 Jan; 26(1):148-154. PubMed ID: 31503360
[TBL] [Abstract][Full Text] [Related]
8. Revisiting signal transducer and activator of transcription 3 (STAT3) as an anticancer target and its inhibitor discovery: Where are we and where should we go?
Huang Q; Zhong Y; Dong H; Zheng Q; Shi S; Zhu K; Qu X; Hu W; Zhang X; Wang Y
Eur J Med Chem; 2020 Feb; 187():111922. PubMed ID: 31810784
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis targeted therapies in acute myeloid leukemia: an update.
Ball S; Borthakur G
Expert Rev Hematol; 2020 Dec; 13(12):1373-1386. PubMed ID: 33205684
[No Abstract] [Full Text] [Related]
10. Rhodium(II) Proximity-Labeling Identifies a Novel Target Site on STAT3 for Inhibitors with Potent Anti-Leukemia Activity.
Minus MB; Liu W; Vohidov F; Kasembeli MM; Long X; Krueger MJ; Stevens A; Kolosov MI; Tweardy DJ; Sison EA; Redell MS; Ball ZT
Angew Chem Int Ed Engl; 2015 Oct; 54(44):13085-9. PubMed ID: 26480340
[TBL] [Abstract][Full Text] [Related]
11. Targeting STAT3 anti-apoptosis pathways with organic and hybrid organic-inorganic inhibitors.
Minus MB; Wang H; Munoz JO; Stevens AM; Mangubat-Medina AE; Krueger MJ; Liu W; Kasembeli MM; Cooper JC; Kolosov MI; Tweardy DJ; Redell MS; Ball ZT
Org Biomol Chem; 2020 May; 18(17):3288-3296. PubMed ID: 32286579
[TBL] [Abstract][Full Text] [Related]
12. Disarming an Electrophilic Warhead: Retaining Potency in Tyrosine Kinase Inhibitor (TKI)-Resistant CML Lines While Circumventing Pharmacokinetic Liabilities.
Ali AM; Gómez-Biagi RF; Rosa DA; Lai PS; Heaton WL; Park JS; Eiring AM; Vellore NA; de Araujo ED; Ball DP; Shouksmith AE; Patel AB; Deininger MW; O'Hare T; Gunning PT
ChemMedChem; 2016 Apr; 11(8):850-61. PubMed ID: 27028877
[TBL] [Abstract][Full Text] [Related]
13. Curcumin Combined with Thalidomide Reduces Expression of
Mohammadi Kian M; Salemi M; Bahadoran M; Haghi A; Dashti N; Mohammadi S; Rostami S; Chahardouli B; Babakhani D; Nikbakht M
Drug Des Devel Ther; 2020; 14():185-194. PubMed ID: 32021103
[TBL] [Abstract][Full Text] [Related]
14. Antagonizing STAT3 dimerization with a rhodium(III) complex.
Ma DL; Liu LJ; Leung KH; Chen YT; Zhong HJ; Chan DS; Wang HM; Leung CH
Angew Chem Int Ed Engl; 2014 Aug; 53(35):9178-82. PubMed ID: 24889897
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
